U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222280) titled 'Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy' on July 21.
Brief Summary: The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease.
* Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting?
* Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzhei...